secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2022-03-30T23:59:59+00:00
Accession:  0001824293-22-000021
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Chairman Ofir Levi resigns from Vallon board; stays as consultant for 12 months at $22,500/quarter
--------------------------------------------------------------------------------

- Ofir Levi resigned as Board member and Chairman effective March 28, 2022, for personal reasons.
- Levi enters 12-month consulting agreement for $22,500 per quarter; unvested options vested immediately.
- Vested options remain exercisable during consulting term and 90 days thereafter.
- Resignation not due to any disagreement with management or operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429322000021/0001824293-22-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429322000021/ck00018242493-20220328.htm
  HTML page:      https://secwatch.observer/filing/0001824293-22-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer